Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Minami

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Neurological Disorders|April 13, 2023
Immunotherapy for ocular myasthenia gravis: an observational study in JapanTomoko Narita, Shunya Nakane, Akiko Nagaishi, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2024
The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System AtrophyMonami Tarisawa, Masaaki Matsushima, Akihiko Kudo, et al.
Clinical Immunology (Orlando, Fla.)|October 29, 2017
Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosisYusei Miyazaki, Masaaki Niino, Eri Takahashi, et al.
Journal of Neuroimmunology|November 27, 2025
Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility studyYusei Miyazaki, Hiroaki Yokote, Juichi Fujimori, et al.
Journal of Neurology|September 17, 2014
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathyShinichi Shirai, Ichiro Yabe, Takahiro Kano, et al.
Journal of Neuroimmunology|September 10, 2016
Fingolimod suppresses bone resorption in female patients with multiple sclerosisYusei Miyazaki, Masaaki Niino, Ippei Kanazawa, et al.
Neurology. Clinical Practice|March 28, 2024
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in JapanShigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, et al.
Internal Medicine (Tokyo, Japan)|June 4, 2025
Corticosteroid-induced Cushingoid Appearance in Myasthenia GravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.
Plos One|August 14, 2025
Predicting achievement of clinical goals using machine learning in myasthenia gravisHiroyuki Akamine, Akiyuki Uzawa, Satoshi Kuwabara, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 6, 2023
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia GravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Neurological Disorders|April 13, 2023
Immunotherapy for ocular myasthenia gravis: an observational study in JapanTomoko Narita, Shunya Nakane, Akiko Nagaishi, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2024
The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System AtrophyMonami Tarisawa, Masaaki Matsushima, Akihiko Kudo, et al.
Clinical Immunology (Orlando, Fla.)|October 29, 2017
Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosisYusei Miyazaki, Masaaki Niino, Eri Takahashi, et al.
Journal of Neuroimmunology|November 27, 2025
Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility studyYusei Miyazaki, Hiroaki Yokote, Juichi Fujimori, et al.
Journal of Neurology|September 17, 2014
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathyShinichi Shirai, Ichiro Yabe, Takahiro Kano, et al.
Journal of Neuroimmunology|September 10, 2016
Fingolimod suppresses bone resorption in female patients with multiple sclerosisYusei Miyazaki, Masaaki Niino, Ippei Kanazawa, et al.
Neurology. Clinical Practice|March 28, 2024
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in JapanShigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, et al.
Internal Medicine (Tokyo, Japan)|June 4, 2025
Corticosteroid-induced Cushingoid Appearance in Myasthenia GravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.
Plos One|August 14, 2025
Predicting achievement of clinical goals using machine learning in myasthenia gravisHiroyuki Akamine, Akiyuki Uzawa, Satoshi Kuwabara, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 6, 2023
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia GravisAkiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, et al.
Pageof 5